Hilary D. Marston | |
---|---|
Alma mater |
Yale College (BA) University of Pennsylvania (MD) Harvard University (MPH) [1] |
Scientific career | |
Fields | Global health, pandemic preparedness |
Institutions | Food and Drug Administration |
Hilary D. Marston is an American physician-scientist and global health policy advisor specializing in pandemic preparedness. She is the Chief Medical Officer of the Food and Drug Administration.
Marston worked for McKinsey & Company and at the Bill & Melinda Gates Foundation as a program officer and special assistant. She then studied internal medicine at Brigham and Women's Hospital. [2] In 2013, Marston joined National Institute of Allergy and Infectious Diseases (NIAID). She has experience in outbreak response, including Zika virus and Ebola. [3] Marston served as a medical officer and policy advisor for global health and pandemic preparedness at NIAID. [4] On April 15, 2020, Marston was the inaugural speaker at the NIH Intramural Research Program's new COVID-19 scientific interest group. Her presentation was titled "The Biomedical Research Response to COVID-19: A View from NIAID." [3] In 2022, Marston joined the US Food and Drug Administration as Chief Medical Officer. [5] She succeeded Janet Woodcock. [5]
Hilary D. Marston | |
---|---|
Alma mater |
Yale College (BA) University of Pennsylvania (MD) Harvard University (MPH) [1] |
Scientific career | |
Fields | Global health, pandemic preparedness |
Institutions | Food and Drug Administration |
Hilary D. Marston is an American physician-scientist and global health policy advisor specializing in pandemic preparedness. She is the Chief Medical Officer of the Food and Drug Administration.
Marston worked for McKinsey & Company and at the Bill & Melinda Gates Foundation as a program officer and special assistant. She then studied internal medicine at Brigham and Women's Hospital. [2] In 2013, Marston joined National Institute of Allergy and Infectious Diseases (NIAID). She has experience in outbreak response, including Zika virus and Ebola. [3] Marston served as a medical officer and policy advisor for global health and pandemic preparedness at NIAID. [4] On April 15, 2020, Marston was the inaugural speaker at the NIH Intramural Research Program's new COVID-19 scientific interest group. Her presentation was titled "The Biomedical Research Response to COVID-19: A View from NIAID." [3] In 2022, Marston joined the US Food and Drug Administration as Chief Medical Officer. [5] She succeeded Janet Woodcock. [5]